D. E. Shaw & Co., Inc. Inovio Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.35 - $0.53 $986,186 - $1.49 Million	-2,817,675 Reduced 51.06%	2,701,162 $1.38 Million
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $791,652 - $1.21 Million	-2,083,296 Reduced 27.4%	5,518,837 $2.15 Million
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $383,482 - $924,291	983,289 Added 14.86%	7,602,133 $3.42 Million
Q1 2023 May 15, 2023	SELL	$0.79 - $1.91 $1.46 Million - $3.54 Million	-1,851,856 Reduced 21.86%	6,618,844 $5.43 Million
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $1.3 Million - $2.3 Million	919,851 Added 12.18%	8,470,700 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $2.58 Million - $4.33 Million	1,552,599 Added 25.88%	7,550,849 $13 Million
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $717,734 - $1.98 Million	498,427 Added 9.06%	5,998,250 $10.4 Million
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $1.44 Million - $2.53 Million	-485,710 Reduced 8.11%	5,499,823 $19.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $10.9 Million - $16.4 Million	2,192,676 Added 57.81%	5,985,533 $29.9 Million
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $12.2 Million - $16.5 Million	1,702,996 Added 81.49%	3,792,857 $27.2 Million
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $7.34 Million - $11.8 Million	1,177,458 Added 129.05%	2,089,861 $19.4 Million
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $242,222 - $466,298	27,494 Added 3.11%	912,403 $8.47 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $5.1 Million - $7.71 Million	600,138 Added 210.74%	884,909 $7.83 Million
Q3 2020 Nov 16, 2020	SELL	$9.57 - $27.05 $1.39 Million - $3.93 Million	-145,329 Reduced 33.79%	284,771 $3.3 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $3.07 Million - $13.6 Million	430,100 New	430,100 $11.6 Million
Q1 2020 May 15, 2020	SELL	$2.98 - $14.09 $1.26 Million - $5.98 Million	-424,474 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $426,083 - $804,583	216,286 Added 103.89%	424,474 $1.4 Million
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $297,563 - $438,362	-145,153 Reduced 41.08%	208,188 $426,000
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $1.51 Million - $2.7 Million	-659,555 Reduced 65.12%	353,341 $1.04 Million
Q1 2019 May 15, 2019	SELL	$3.34 - $5.1 $201,034 - $306,969	-60,190 Reduced 5.61%	1,012,896 $3.78 Million
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $2.32 Million - $3.65 Million	596,684 Added 125.25%	1,073,086 $4.29 Million
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $1.23 Million - $1.75 Million	313,015 Added 191.58%	476,402 $2.65 Million
Q2 2018 Aug 14, 2018	SELL	$3.88 - $5.16 $579,031 - $770,052	-149,235 Reduced 47.74%	163,387 $640,000
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $174,640 - $245,358	43,121 Added 16.0%	312,622 $1.47 Million
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $1.31 Million - $2.13 Million	-318,398 Reduced 54.16%	269,501 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $3.15 Million - $3.74 Million	587,899	587,899 $3.73 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $506M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account